International Wound Journal · 2013 · 263 citations · 27 references
Veterinary MedicineOrthopaedic SurgerySurgeryDiabetic Foot CareRegenerative MedicineWound HealingDiabetic Foot Ulcer CareSurgical Wound HealingUlcer ManagementWound CareWound Healing ResponseWound ManagementAmniotic Membrane TherapyDiabetic Wound HealingDiabetic Wound RepairHealing Outcome MeasurementParallel Study DesignsPostoperative Wound HealingStandard Of Care ComparatorsWound Healing Outcome Assessment
The study compared healing of diabetic foot ulcers treated with dehydrated human amniotic membrane allografts (EpiFix) to standard care. In a prospective, randomized, single‑centre trial, patients with non‑infected ulcers ≥4 weeks and adequate perfusion were randomized to standard care alone or with EpiFix, and wound size reduction and complete healing at 4 and 6 weeks were assessed. EpiFix produced markedly greater wound size reduction (≈97 % vs 32 % at 4 weeks, ≈98 % vs –1.8 % at 6 weeks) and higher healing rates (77 % and 92 % vs 0 % and 8 %) compared with standard care, demonstrating its efficacy.
Abstract Our purpose was to compare healing characteristics of diabetic foot ulcers treated with dehydrated human amniotic membrane allografts ( EpiFix ®, MiMedx , Kennesaw, GA ) versus standard of care. An IRB ‐approved, prospective, randomised, single‐centre clinical trial was performed. Included were patients with a diabetic foot ulcer of at least 4‐week duration without infection having adequate arterial perfusion. Patients were randomised to receive standard care alone or standard care with the addition of EpiFix . Wound size reduction and rates of complete healing after 4 and 6 weeks were evaluated. In the standard care group ( n = 12) and the EpiFix group ( n = 13) wounds reduced in size by a mean of 32·0% ± 47·3% versus 97·1% ± 7·0% ( P < 0·001) after 4 weeks, whereas at 6 weeks wounds were reduced by −1·8% ± 70·3% versus 98·4% ± 5·8% ( P < 0·001), standard care versus EpiFix , respectively. After 4 and 6 weeks of treatment the overall healing rate with application of EpiFix was shown to be 77% and 92%, respectively, whereas standard care healed 0% and 8% of the wounds ( P < 0·001), respectively. Patients treated with EpiFix achieved superior healing rates over standard treatment alone. These results show that using EpiFix in addition to standard care is efficacious for wound healing.
27
Comprehensive Foot Examination and Risk Assessment
Andrew J.M. Boulton, David G. Armstrong, Stephen F. Albert et al. · Diabetes Care · 2008 · 920 citations · Full text
Health Professions, Orthopaedic Surgery, Orthopedic Surgery +14
Identification of Antiangiogenic and Antiinflammatory Proteins in Human Amniotic Membrane
Yanxia Hao, David Hui‐Kang, David G. Hwang et al. · Cornea · 2000 · 686 citations
Peter Sheehan, Peter Jones, Antonella Caselli et al. · Diabetes Care · 2003 · 577 citations · Full text
Scheffer C.G. Tseng, De-Quan Li, Xiang Ma · Journal of Cellular Physiology · 1999 · 487 citations